Maryland 2024 Regular Session

Maryland House Bill HB1121

Introduced
2/7/24  

Caption

Public Health - Opioids and Opioid Overdose Reversal Drugs - Information

Impact

The implementation of HB1121 is expected to have a significant impact on state laws surrounding opioid prescriptions and public health. By mandating that healthcare providers share critical information with patients, the bill aims to enhance public awareness and safety regarding opioid use. The anticipated outcome is a reduction in opioid-related overdoses and associated fatalities, as patients will be better informed about the risks and available preventive measures. This will create a more responsible prescribing environment and encourages healthcare professionals to engage more actively in patient education regarding opioid use.

Summary

House Bill 1121 addresses the critical public health issue of opioid prescriptions and the associated risks of overdose. The bill requires licensed health care providers who prescribe or dispense opioids and opioid overdose reversal drugs to furnish specific information to individuals receiving these prescriptions. This includes potential dangers of opioid use, strategies for overdose prevention, and the availability of FDA-approved opioid antagonists that can reverse respiratory depression due to overdose. Pharmacists are also allowed to meet this requirement by posting the necessary information in a conspicuous location, making it accessible to patients.

Contention

Some potential points of contention regarding HB1121 may arise from the responsibility placed on healthcare providers and pharmacists to ensure that patients receive this information. Critics may argue that the bill imposes additional burdens on healthcare providers who are already managing a high volume of patients. There may also be concerns about the effectiveness of posting information in pharmacies rather than having direct conversations between prescribers and patients. Supporters would likely counter that the requirement is essential for protecting public health and could significantly reduce opioid misuse and overdose deaths.

Companion Bills

No companion bills found.

Previously Filed As

MD HB571

Opioids - Opioid Restitution Advisory Council and Fund and Overdose Response Program

MD SB954

Opioids - Opioid Restitution Advisory Council and Fund and Overdose Response Program

MD HB570

Public Health – Prescription Opioids – Deactivation Systems

MD HB1227

Prescription Drug Monitoring Program - Dispensers - Veterinarians

MD HB953

Public Health – Overdose and Infectious Disease Prevention Services Program

MD SB618

Public Health – Overdose and Infectious Disease Prevention Services Program

MD SB786

Health - Reproductive Health Services - Protected Information and Insurance Requirements

MD HB812

Health - Reproductive Health Services - Protected Information and Insurance Requirements

MD SB532

Criminal Law - Overdosing in Public - Prohibition

MD HB667

Criminal Law - Overdosing in Public - Prohibition

Similar Bills

No similar bills found.